Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire

<p>Abstract</p> <p>Background</p> <p>In resource-limited settings where nevirapine-containing regimen is the preferred regimen in women, data on severe adverse events (SAEs) according to CD4 cell count are limited. We estimated the incidence of SAEs according to CD4 cell count and identify their ris...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Amani-Bosse Clarisse, Tanon Aristophane K, Tonwe-Gold Besigin, Coffie Patrick A, Bédikou Gédéon, Abrams Elaine J, Dabis François, Ekouevi Didier K
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2010-06-01
Serie:	BMC Infectious Diseases
Accesso online:	http://www.biomedcentral.com/1471-2334/10/188
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!